UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
SEC FILE NUMBER
000-0331369
NOTIFICATION OF LATE FILING
(CHECK ONE): | | Form 10-K |_| Form 20-F |_| Form 11-K [x] Form 10-QSB
|_| Form N-SAR
For Period Ended: June 30, 2003
/ / Transition Report on Form 10-K [ ]
/ / Transition Report on Form 20-F [ ]
/ / Transition Report on Form 11-K [ ]
/ / Transition Report on Form 10-Q [ ]
/ / Transition Report on Form N-SAR
For the Transition Period Ended: _______________________________________
NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS
VERIFIED ANY INFORMATION CONTAINED HEREIN.
--------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
Not Applicable
--------------------------------------------------------------------------------
PART I - REGISTRANT INFORMATION
CRITICAL HOME CARE, INC.
--------------------------------------------------------------------------------
Full Name of Registrant
New York Medical, Inc.
--------------------------------------------------------------------------------
Former Name if Applicable
762 SUMMA AVENUE
--------------------------------------------------------------------------------
Address of Principal Executive Officer (Street and Number)
WESTBURY, NEW YORK 11590
--------------------------------------------------------------------------------
City, State and Zip Code
PART II - RULES 12b-25(b) AND (C)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25)b), the
following should be completed. (Check box if appropriate) [X] YES [ ] NO
[x] (a)The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[x] (b)The subject annual report, semi-annual report, transition report
on Form 10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof, will be
filed on or before the fifteenth calendar day following the prescribed
due date; or the subject quarterly report of transition report Form
10-Q, or portion thereof will be filed on or before the fifth calendar
day following the prescribed due date; and
[ ] (c)The accountant's statement or other exhibit required by Rule
12-b-25(C) has been attached if applicable.
PART III - NARRATIVE
State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed time period. (Attach Extra Sheets if Needed)
The Company could not complete the consolidating and consolidated financial
statements without unreasonable effort and expense.
PART IV - OTHER INFORMATION
(1) Name and telephone number of person to contact in regard to this
notification
Eric Yonenson 516-997-1200
(2) Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months (of for such
shorter) period that the registrant was required to file such reports)
been filed? If answer is no, identify report(s). Yes |X| No | |
----------------------------------------------------------------------
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject
report or portion thereof? Yes |X |No | |
If so, attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
Preliminary results of operations for the three and nine months ended June
30, 2003 reflect a net loss of approximately $1,730,000 and $2,830,000,
respectively, compared to net loss of $15,000 and net income of $52,000,
respectively, for the three and nine months ended June 30, 2002. The current
year results include the operations of Classic Healthcare Solutions, Inc.,
Homecare Alliance, Inc. and All Care Medical Products, Inc. Prior year results
are only that of Classic Healthcare Solutions, Inc. In addition, the three and
nine months ended June 30, 2003 include a charge for the impairment of goodwill
of approximately $1,500,000, for which no comparable prior year expense exists.
Additionally, the nine months ended June 30, 2003 includes a charge of $666,000
for amortization of debt discount and beneficial conversion feature for which no
comparable prior year expense exists.
These results are subject to further review and adjustment.
--------------------------------------------------------------------------------
Critical Home Care, Inc.
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date: August 13, 2003 By: /s/ David Bensol
-----------------------
David Bensol
Chief Executive Officer